These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16394444)

  • 1. Lichenoid eruption due to imatinib.
    Prabhash K; Doval DC
    Indian J Dermatol Venereol Leprol; 2005; 71(4):287-8. PubMed ID: 16394444
    [No Abstract]   [Full Text] [Related]  

  • 2. Imatinib for chronic myeloid leukaemia: a NICE mess.
    Lim D; Muir J
    Lancet; 2001 Dec; 358(9296):1903. PubMed ID: 11741656
    [No Abstract]   [Full Text] [Related]  

  • 3. Lichenoid drug eruption with hyperpigmentation caused by imatinib mesylate.
    Kagimoto Y; Mizuashi M; Kikuchi K; Aiba S
    Int J Dermatol; 2014 Mar; 53(3):e161-2. PubMed ID: 23786260
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiple skin lesions caused by imatinib mesylate treatment of chronic myeloid leukemia.
    Machaczka M; Gossart M
    Pol Arch Med Wewn; 2013; 123(5):251-2. PubMed ID: 23722191
    [No Abstract]   [Full Text] [Related]  

  • 5. Trachyonychia in a patient with chronic myeloid leukaemia after imatinib mesylate.
    Lau YM; Lam YK; Leung KH; Lin SY
    Hong Kong Med J; 2014 Oct; 20(5):464.e2. PubMed ID: 25307080
    [No Abstract]   [Full Text] [Related]  

  • 6. Cutaneous lichenoid eruption caused by imatinib mesylate in a Japanese patient with chronic myeloid leukaemia.
    Kawakami T; Kawanabe T; Soma Y
    Acta Derm Venereol; 2009; 89(3):325-6. PubMed ID: 19479144
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral lichenoid reaction to imatinib (STI 571, Gleevec).
    Lim DS; Muir J
    Dermatology; 2002; 205(2):169-71. PubMed ID: 12218235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous Lichenoid dermatitis associated with imatinib mesylate.
    Chan CY; Browning J; Smith-Zagone MJ; Martinelli PT; Hsu S
    Dermatol Online J; 2007 May; 13(2):29. PubMed ID: 17498448
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral and cutaneous lichenoid reaction secondary to imatinib: report of two cases.
    Pascual JC; Matarredona J; Miralles J; Conesa V; Borras-Blasco J
    Int J Dermatol; 2006 Dec; 45(12):1471-3. PubMed ID: 17184272
    [No Abstract]   [Full Text] [Related]  

  • 10. Imatinib-associated lichenoid eruption: acitretin treatment allows maintained antineoplastic effect.
    Dalmau J; Peramiquel L; Puig L; Fernández-Figueras MT; Roé E; Alomar A
    Br J Dermatol; 2006 Jun; 154(6):1213-6. PubMed ID: 16704665
    [No Abstract]   [Full Text] [Related]  

  • 11. Lichenoid drug eruption related to imatinib: report of a new case and review of the literature.
    Sendagorta E; Herranz P; Feito M; Ramírez P; Feltes R; Floristán U; Mariño-Enriquez A; Casado M
    Clin Exp Dermatol; 2009 Oct; 34(7):e315-6. PubMed ID: 19456782
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral lichenoid eruption associated with imatinib treatment.
    Gómez Fernández C; Sendagorta Cudós E; Casado Verrier B; Feito Rodríguez M; Suárez Aguado J; Vidaurrázaga Díaz de Arcaya C
    Eur J Dermatol; 2010; 20(1):127-8. PubMed ID: 19825526
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lichenoid cutaneous reaction to imatinib].
    Roux C; Boisseau-Garsaud AM; Saint-Cyr I; Hélénon R; Quist D; Delaunay C
    Ann Dermatol Venereol; 2004; 131(6-7 Pt 1):571-3. PubMed ID: 15318140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photosensitization in chronic myelogenous leukaemia patients treated with imatinib mesylate.
    Rousselot P; Larghero J; Raffoux E; Calvo F; Tulliez M; Giraudier S; Rybojad M
    Br J Haematol; 2003 Mar; 120(6):1091-2. PubMed ID: 12648085
    [No Abstract]   [Full Text] [Related]  

  • 15. Lichenoid eruption to STI 571.
    Lim D; Muir J
    Am J Hematol; 2002 Jun; 70(2):179. PubMed ID: 12111794
    [No Abstract]   [Full Text] [Related]  

  • 16. Lichenoid drug eruption with palmoplantar hyperkeratosis due to imatinib mesylate: a case report and a review of the literature.
    Kuraishi N; Nagai Y; Hasegawa M; Ishikawa O
    Acta Derm Venereol; 2010; 90(1):73-6. PubMed ID: 20107730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imatinib induced Stevens-Johnson syndrome: lack of recurrence following re-challenge with a lower dose.
    Pavithran K; Thomas M
    Indian J Dermatol Venereol Leprol; 2005; 71(4):288-9. PubMed ID: 16394445
    [No Abstract]   [Full Text] [Related]  

  • 18. Precipitation of porphyria cutanea tarda by imatinib mesylate?
    Ho AY; Deacon A; Osborne G; Mufti GJ
    Br J Haematol; 2003 Apr; 121(2):375. PubMed ID: 12694262
    [No Abstract]   [Full Text] [Related]  

  • 19. Imatinib mesylate induced immune thrombocytopenia.
    Rajappa S; Varadpande L; Paul TR; Digumarti R
    Leuk Lymphoma; 2007 Nov; 48(11):2261-3. PubMed ID: 17926182
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful management of liver injury caused by imatinib mesylate in a patient with previously untreated chronic myelogenous leukemia in the chronic phase.
    Yamazaki R; Okamoto S; Chen CK; Tada S; Saito H; Shibata R; Sakamoto M; Mori T; Ikeda Y
    Leuk Lymphoma; 2006 Jul; 47(7):1427-30. PubMed ID: 16923586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.